Muni Not‑for‑Profit Healthcare 2018: Keep an Eye on Quality

Credit challenges underscore the need for active credit selection in the muni healthcare segment.

The policy outlook for U.S. not-for-profit (NFP) healthcare has stabilized somewhat after a turbulent 2017, when repeated congressional attempts to repeal and replace the Affordable Care Act (ACA) and uncertainties about tax reform tested the sector. Despite these credit headwinds, bond spreads tightened significantly over the course of the year in all rating categories, marking a return to more normal levels after having widened substantially following the November 2016 elections (see Figure 1). With help from a favorable technical environment, healthcare ended 2017 as the best-performing investment-grade muni bond sector (see Figure 2).

We expect the favorable technical backdrop to support continued relative outperformance this year, but note that credit challenges – including rising labor costs and lower reimbursement – remain in play. Active credit selection will therefore continue to drive performance, and we maintain our bias in favor of higher-quality issuers. We expect an aging population and other demographic changes in the U.S. to result in higher utilization of healthcare services. However, reimbursement challenges will limit top-line revenue growth, and rising healthcare costs will likely spur greater price awareness among consumers, employers and lawmakers. This will require NFP health systems to make sizable investments to redesign their care delivery systems to provide lower-cost, higher-quality patient care. Strong credit fundamentals will be paramount to support these investments.

Insights for 2018: Remain invested, with a focus on quality

We expect a more stable federal healthcare policy environment this year, as future efforts to fully repeal the ACA are unlikely to be successful. While the U.S. tax reform bill passed in December 2017 included a repeal of the ACA’s individual mandate penalty (effective in 2019), Medicaid remains intact as an open-ended entitlement program for approximately 70 million Americans. Additionally, the recently passed federal budget included 10 years of funding for the Children’s Health Insurance Program (CHIP), delayed the ACA’s disproportionate share hospital (DSH) cuts by two more years, renewed so-called Medicare “extenders” and eliminated the Independent Payment Advisory Board (IPAB) – all generally favorable for NFP health systems. 

Credit challenges remain, however, including rising uninsured and “underinsured” patient populations, which will result in higher uncompensated care and lower revenue growth for NFP health systems. ACA market enrollment declined by 3.8% during the open enrollment period for the 2018 plan year,1 and we expect this trend to continue over the next several years. An increasing number of patients with high-deductible health plans will also negatively affect revenue collections for NFP health systems. This is key at a time when rising labor and pharmaceutical costs are already resulting in margin contraction for many NFP health systems.

Issuance is set to fall

We expect a significant decline in U.S. federal tax-exempt healthcare muni issuance after a spike to record-breaking levels in December 2017 (tax exemption refers to interest income and is limited to U.S. residents). Issuers rushed to the market late last year amid fears of a U.S. tax reform proposal that would have eliminated private activity bonds (PABs), the primary vehicles through which NFP health systems issue U.S. federal tax-exempt debt. We estimate that roughly $10 billion of healthcare issuance was pulled forward into December 2017. While healthcare has represented 11% of muni issuance for the past two years, this figure has dropped to just 4% of new debt to date in 2018. If this trend continues, the resulting scarcity value should provide a tailwind for healthcare spreads.

Remain selective

While we expect healthcare spreads to provide relative outperformance versus other muni bond sectors given a supportive technical backdrop, selecting and investing in the most promising credits will remain vital given reimbursement pressure and growing expenses in the sector. The benefits of Medicaid expansion – namely, a lower uninsured rate and higher utilization – peaked in 2015, and revenue growth slowed in 2016 and 2017. State-specific changes to Medicaid programs, including work requirements, could result in an increase in the uninsured rate in certain markets. Shifting utilization trends from inpatient to outpatient services, increasing use of high-deductible health plans and a growing Medicare population will also limit revenue growth. Low unemployment and a nationwide nursing shortage are pushing labor costs up, and rising costs for medical supplies and pharmaceuticals will also continue to pressure many NFP health systems’ operating performance.

For these reasons, we remain underweight and cautious on single-site hospitals, rural hospitals, and health systems that rely heavily on governmental payers. These types of providers are generally less able to respond swiftly to operating pressures.

Merger mania will likely continue

We expect continued consolidation in the sector in response to the operating challenges highlighted above, through both horizontal and vertical mergers and acquisitions. As Figure 3 shows, the crescendo of health system mergers in recent years reached a new high in 2017,2 and we expect the trend to continue this year. Mergers can benefit NFP health systems by improving their bargaining power with managed care and commercial payers, and over the longer term, generating cost savings and producing synergies and integrated care. But we believe bigger is not necessarily better; mergers are challenging to execute and often result in increased leverage and weakened operating performance in the initial years of integration. We prefer regional health systems with strong credit quality and good market positions to lower-rated multistate systems and single-site hospitals. In our view, regional health systems offering services across a continuum of care are nimble enough to respond to their local market dynamics, but large enough to achieve economies of scale.

Beyond 2018: a high-cost industry ripe for disruption

As healthcare spending increases and becomes a larger and larger segment of the U.S. economy, we believe the sector is poised for disruption. National health expenditures are projected to reach nearly 20% of total U.S. GDP by 2026,3 driven primarily by rising prices for medical services and shifts in enrollment from private insurance to Medicare as baby boomers age (see Figure 4). While we do not anticipate major U.S. entitlement reform in 2018, we expect the federal government will eventually be forced to make cuts to Medicare and Medicaid due to large looming federal deficits. We view such declines in federal reimbursement as a key risk for the sector.

In addition, as out-of-pocket healthcare costs rise, we expect NFP health systems will continue to face scrutiny from consumers, employers and public officials. This will require greater transparency and the need for NFPs to demonstrate that they can provide better value and improved care coordination for patients. If NFP health systems cannot deliver, patients will seek care in lower-cost and more convenient settings. For example, recently announced vertical integrations of non-hospital providers, such as CVS and Aetna and potentially Walmart and Humana, could result in patient care increasingly being delivered outside of an NFP health system’s network. Employers’ focus on reducing healthcare costs – as exemplified by the Amazon/Berkshire Hathaway/JPMorgan partnership ­– also has the potential to be disruptive for the sector.

We believe successful NFP health systems of the future will offer vertically integrated networks of physicians and other non-hospital facilities, patient-centered care delivery models, pricing transparency and a strong value proposition for consumers. Achieving these capabilities will require substantial investments, so strong underlying credit fundamentals are essential. Thoughtful management teams, good balance sheets and operating performance, and a strong market position are the key characteristics PIMCO looks for when investing in NFP health systems.

To receive up-to-date municipal market insights from PIMCO, subscribe to our Muni Insights list.
(Generally one to three key emails per quarter. Unsubscribe at any time.)

1 See “Health Insurance Exchanges 2018 Open Enrollment Period Final Report,” published April 2018 by the Centers for Medicare & Medicaid Services.
2 See “2017 in Review: The Year M&A Shook the Healthcare Landscape,” by Kaufman, Hall & Associates, LLC.
3 See “National Health Expenditure Projections, 2017–26: Despite Uncertainty, Fundamentals Primarily Drive Spending Growth,” published 14 February 2018 by Gigi A. Cuckler, Andrea M. Sisko, John A. Poisal et al.
The Author

Rachel Betton

Portfolio Manager, Municipal Bonds

View Profile

Latest Insights



PIMCO provides services only to qualified institutions and investors. This is not an offer to any person in any jurisdiction where unlawful or unauthorized. | Pacific Investment Management Company LLC, 650 Newport Center Drive, Newport Beach, CA 92660 is regulated by the United States Securities and Exchange Commission. | PIMCO Europe Ltd (Company No. 2604517) and PIMCO Europe Ltd - Italy (Company No. 07533910969) are authorised and regulated by the Financial Conduct Authority (12 Endeavour Square, London E20 1JN) in the UK. The Italy branch is additionally regulated by the Commissione Nazionale per le Società e la Borsa (CONSOB) in accordance with Article 27 of the Italian Consolidated Financial Act. PIMCO Europe Ltd services are available only to professional clients as defined in the Financial Conduct Authority’s Handbook and are not available to individual investors, who should not rely on this communication. | PIMCO Deutschland GmbH (Company No. 192083, Seidlstr. 24-24a, 80335 Munich, Germany), PIMCO Deutschland GmbH Italian Branch (Company No. 10005170963), PIMCO Deutschland GmbH Spanish Branch (N.I.F. W2765338E) and PIMCO Deutschland GmbH Swedish Branch (SCRO Reg. No. 516410-9190) are authorised and regulated by the German Federal Financial Supervisory Authority (BaFin) (Marie- Curie-Str. 24-28, 60439 Frankfurt am Main) in Germany in accordance with Section 32 of the German Banking Act (KWG). The Italian Branch, Spanish Branch and Swedish Branch are additionally supervised by the Commissione Nazionale per le Società e la Borsa (CONSOB) in accordance with Article 27 of the Italian Consolidated Financial Act, the Comisión Nacional del Mercado de Valores (CNMV) in accordance with obligations stipulated in articles 168 and  203  to 224, as well as obligations contained in Tile V, Section I of the Law on the Securities Market (LSM) and in articles 111, 114 and 117 of Royal Decree 217/2008 and the Swedish Financial Supervisory Authority (Finansinspektionen) in accordance with Chapter 25 Sections 12-14 of the Swedish Securities Markets Act, respectively. The services provided by PIMCO Deutschland GmbH are available only to professional clients as defined in Section 67 para. 2 German Securities Trading Act (WpHG). They are not available to individual investors, who should not rely on this communication. | PIMCO (Schweiz) GmbH (registered in Switzerland, Company No. CH-, Brandschenkestrasse 41, 8002 Zurich, Switzerland, Tel: + 41 44 512 49 10. The services provided by PIMCO (Schweiz) GmbH are not available to individual investors, who should not rely on this communication but contact their financial adviser. | PIMCO Asia Pte Ltd (8 Marina View, #30-01, Asia Square Tower 1, Singapore 018960, Registration No. 199804652K) is regulated by the Monetary Authority of Singapore as a holder of a capital markets services licence and an exempt financial adviser. The asset management services and investment products are not available to persons where provision of such services and products is unauthorised. | PIMCO Asia Limited (Suite 2201, 22nd Floor, Two International Finance Centre, No. 8 Finance Street, Central, Hong Kong) is licensed by the Securities and Futures Commission for Types 1, 4 and 9 regulated activities under the Securities and Futures Ordinance. The asset management services and investment products are not available to persons where provision of such services and products is unauthorised. | PIMCO Australia Pty Ltd ABN 54 084 280 508, AFSL 246862 (PIMCO Australia). This publication has been prepared without taking into account the objectives, financial situation or needs of investors. Before making an investment decision, investors should obtain professional advice and consider whether the information contained herein is appropriate having regard to their objectives, financial situation and needs. | PIMCO Japan Ltd (Toranomon Towers Office 18F, 4-1-28, Toranomon, Minato-ku, Tokyo, Japan 105-0001) Financial Instruments Business Registration Number is Director of Kanto Local Finance Bureau (Financial Instruments Firm) No. 382. PIMCO Japan Ltd is a member of Japan Investment Advisers Association and The Investment Trusts Association, Japan. Investment management products and services offered by PIMCO Japan Ltd are offered only to persons within its respective jurisdiction, and are not available to persons where provision of such products or services is unauthorized. Valuations of assets will fluctuate based upon prices of securities and values of derivative transactions in the portfolio, market conditions, interest rates and credit risk, among others. Investments in foreign currency denominated assets will be affected by foreign exchange rates. There is no guarantee that the principal amount of the investment will be preserved, or that a certain return will be realized; the investment could suffer a loss. All profits and losses incur to the investor. The amounts, maximum amounts and calculation methodologies of each type of fee and expense and their total amounts will vary depending on the investment strategy, the status of investment performance, period of management and outstanding balance of assets and thus such fees and expenses cannot be set forth herein. | PIMCO Taiwan Limited is managed and operated independently. The reference number of business license of the company approved by the competent authority is (107) FSC SICE Reg. No.001. 40F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (R.O.C.), Tel: +886 (02) 8729-5500. | PIMCO Canada Corp. (199 Bay Street, Suite 2050, Commerce Court Station, P.O. Box 363, Toronto, ON, M5L 1G2) services and products may only be available in certain provinces or territories of Canada and only through dealers authorized for that purpose. | PIMCO Latin America Av. Brigadeiro Faria Lima 3477, Torre A, 5° andar São Paulo, Brazil 04538-133. | No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. PIMCO is a trademark of Allianz Asset Management of America L.P. in the United States and throughout the world.

Past performance is not a guarantee or a reliable indicator of future results.

Investing in the bond market is subject to risks, including market, interest rate, issuer, credit, inflation risk, and liquidity risk. The value of most bonds and bond strategies are impacted by changes in interest rates. Bonds and bond strategies with longer durations tend to be more sensitive and volatile than those with shorter durations; bond prices generally fall as interest rates rise, and the current low interest rate environment increases this risk. Current reductions in bond counterparty capacity may contribute to decreased market liquidity and increased price volatility. Bond investments may be worth more or less than the original cost when redeemed. Income from municipal bonds for U.S. residents may be subject to state and local taxes and at times the alternative minimum tax. PIMCO does not provide legal or tax advice. Please consult your tax and/or legal counsel for specific tax or legal questions and concerns.

There is no guarantee that these investment strategies will work under all market conditions or are suitable for all investors and each investor should evaluate their ability to invest long-term, especially during periods of downturn in the market. Investors should consult their investment professional prior to making an investment decision.

The credit quality of a particular security or group of securities does not ensure the stability or safety of an overall portfolio. The quality ratings of individual issues/issuers are provided to indicate the credit-worthiness of such issues/issuer and generally range from AAA, Aaa, or AAA (highest) to D, C, or D (lowest) for S&P, Moody’s, and Fitch respectively.

References to specific securities and their issuers are not intended and should not be interpreted as recommendations to purchase, sell or hold such securities. PIMCO products and strategies may or may not include the securities referenced and, if such securities are included, no representation is being made that such securities will continue to be included.

This material contains the opinions of the manager and such opinions are subject to change without notice. This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. It is not possible to invest directly in an unmanaged index. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. PIMCO is a trademark of Allianz Asset Management of America L.P. in the United States and throughout the world. ©2018, PIMCO.